Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.024 seconds
[en] In the first part of this contribution the authors report on the follow-up of patients, who at first presentation had both enhancing and non-enhancing MRI-lesions. The second part is confined to the use of MRI in monitoring disease evolution in controlled and pilot trials. (author). 9 refs.; 1 fig
Source
Wiethoelter, Horst; Dichgans, Johannes (University of Tuebingen (Germany). Neurological Clinic); Mertin, Juergen (Allensbach (Germany)) (eds.); International Congress Series; no. 960; 404 p; ISBN 0 444 81416 7; 
; 1991; p. 23-28; Excerpta Medica; Amsterdam (Netherlands); 6. Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Tuebingen (Germany, F.R.); 11-13 Oct 1990
; 1991; p. 23-28; Excerpta Medica; Amsterdam (Netherlands); 6. Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Tuebingen (Germany, F.R.); 11-13 Oct 1990